| Year |
Citation |
Score |
| 2024 |
Malek R, Sałat K, Totoson P, Karcz T, Refouvelet B, Skrzypczak-Wiercioch A, Maj M, Simakov A, Martin H, Siwek A, Szałaj N, Godyń J, Panek D, Więckowska A, Jozwiak K, et al. Discovery of New Highly Potent Histamine H Receptor Antagonists, Calcium Channel Blockers, and Acetylcholinesterase Inhibitors. Acs Chemical Neuroscience. PMID 39208251 DOI: 10.1021/acschemneuro.4c00341 |
0.657 |
|
| 2024 |
Pachón-Angona I, Bernard PJ, Simakov A, Maj M, Jozwiak K, Novotna A, Lemke C, Gütschow M, Martin H, Oset-Gasque MJ, Contelles JM, Ismaili L. Design and Synthesis of Multi-Functional Ligands through Hantzsch Reaction: Targeting Ca Channels, Activating Nrf2 and Possessing Cathepsin S Inhibitory, and Antioxidant Properties. Pharmaceutics. 16. PMID 38258131 DOI: 10.3390/pharmaceutics16010121 |
0.662 |
|
| 2023 |
Zaręba P, Łątka K, Mazur G, Gryzło B, Pasieka A, Godyń J, Panek D, Skrzypczak-Wiercioch A, Höfner GC, Latacz G, Maj M, Espargaró A, Sabaté R, Jóźwiak K, Wanner KT, et al. Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. 261: 115832. PMID 37837674 DOI: 10.1016/j.ejmech.2023.115832 |
0.604 |
|
| 2023 |
Dakhlaoui I, Bernard PJ, Pietrzak D, Simakov A, Maj M, Refouvelet B, Béduneau A, Cornu R, Jozwiak K, Chabchoub F, Iriepa I, Martin H, Marco-Contelles J, Ismaili L. Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer's Disease Treatment. International Journal of Molecular Sciences. 24. PMID 37298693 DOI: 10.3390/ijms24119742 |
0.651 |
|
| 2022 |
Malek R, Simakov A, Davis A, Maj M, Bernard PJ, Wnorowski A, Martin H, Marco-Contelles J, Chabchoub F, Dallemagne P, Rochais C, Jozwiak K, Ismaili L. Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation. Molecules (Basel, Switzerland). 28. PMID 36615267 DOI: 10.3390/molecules28010071 |
0.664 |
|
| 2021 |
Pachón-Angona I, Maj M, Wnorowski A, Martin H, Jóźwiak K, Ismaili L. Synthesis of new Hantzsch adducts showing Ca channel blockade capacity, cholinesterase inhibition and antioxidant power. Future Medicinal Chemistry. PMID 34402661 DOI: 10.4155/fmc-2021-0176 |
0.65 |
|
| 2021 |
Targowska-Duda KM, Budzynska B, Michalak A, Wnorowski A, Loland CJ, Maj M, Manetti D, Romanelli MN, Jozwiak K, Biala G, Arias HR. Type I and type II positive allosteric modulators of α7 nicotinic acetylcholine receptors induce antidepressant-like activity in mice by a mechanism involving receptor potentiation but not neurotransmitter reuptake inhibition. Correlation with mTOR intracellular pathway activation. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 52: 31-47. PMID 34237657 DOI: 10.1016/j.euroneuro.2021.06.006 |
0.516 |
|
| 2021 |
Zaręba P, Sałat K, Höfner GC, Łątka K, Bajda M, Latacz G, Kotniewicz K, Rapacz A, Podkowa A, Maj M, Jóźwiak K, Filipek B, Wanner KT, Malawska B, Kulig K. Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity. European Journal of Medicinal Chemistry. 221: 113512. PMID 34015586 DOI: 10.1016/j.ejmech.2021.113512 |
0.571 |
|
| 2021 |
Tedesco D, Maj M, Malarczyk P, Cingolani A, Zaffagnini M, Wnorowski A, Czapiński J, Benelli T, Mazzoni R, Bartolini M, Jóźwiak K. Application of the SMALP technology to the isolation of GPCRs from low-yielding cell lines. Biochimica Et Biophysica Acta. Biomembranes. 183641. PMID 33984320 DOI: 10.1016/j.bbamem.2021.183641 |
0.501 |
|
| 2020 |
Pachón Angona I, Martin H, Daniel S, Moraleda I, Bonet A, Wnorowski A, Maj M, Jozwiak K, Iriepa I, Refouvelet B, Marco-Contelles J, Ismaili L. Synthesis of Hantzsch Adducts as Cholinesterases and Calcium Flux inhibitors, Antioxidants and Neuroprotectives. International Journal of Molecular Sciences. 21. PMID 33081112 DOI: 10.3390/ijms21207652 |
0.663 |
|
| 2020 |
Pachòn Angona I, Daniel S, Martin H, Bonet A, Wnorowski A, Maj M, Jóźwiak K, Silva TB, Refouvelet B, Borges F, Marco-Contelles J, Ismaili L. Design, Synthesis and Biological Evaluation of New Antioxidant and Neuroprotective Multitarget Directed Ligands Able to Block Calcium Channels. Molecules (Basel, Switzerland). 25. PMID 32183349 DOI: 10.3390/Molecules25061329 |
0.683 |
|
| 2019 |
Malek R, Maj M, Wnorowski A, Jóźwiak K, Martin H, Iriepa I, Moraleda I, Chabchoub F, Marco-Contelles J, Ismaili L. Multi-target 1,4-dihydropyridines showing calcium channel blockade and antioxidant capacity for Alzheimer's disease therapy. Bioorganic Chemistry. 91: 103205. PMID 31446330 DOI: 10.1016/J.Bioorg.2019.103205 |
0.661 |
|
| 2018 |
Chioua M, Buzzi E, Moraleda I, Iriepa I, Maj M, Wnorowski A, Giovannini C, Tramarin A, Portali F, Ismaili L, López-Alvarado P, Bolognesi ML, Jóźwiak K, Menéndez JC, Marco-Contelles J, et al. Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease. European Journal of Medicinal Chemistry. 155: 839-846. PMID 29958119 DOI: 10.1016/J.Ejmech.2018.06.044 |
0.672 |
|
| Show low-probability matches. |